Ping An Insurance (Group) Company of China has unveiled a range of innovative AI products and services at the World Artificial Intelligence Conference 2026.
Ping An’s latest healthcare AI applications focus on two key areas: complex disease diagnosis and treatment, and every day health management, helping make high-quality healthcare resources more accessible and efficient. For the diagnosis and treatment of complex diseases, Ping An launched its first “disease-specific AI product portfolio” for patients with cancer and other critical illnesses. The portfolio includes three categories of products and services: disease prediction, disease-specific insurance and the Peking University Healthcare AI Disease Manager.
The disease prediction service identifies health risks and helps detect high-risk individuals at an early stage. Disease-specific insurance provides coverage and protection for people with chronic diseases, cancer and other elevated health risks. The Peking University Healthcare AI Disease Manager offers full-course cancer management by connecting patients with physicians, hospitals and rehabilitation resources, providing ongoing support for people with critical illnesses. Together, these products and services connect disease risk identification, insurance protection and professional healthcare services.
AI delivers real-time responses and 24/7 service, efficiently handling high-frequency needs such as consultation triage, medication reminders and health check report interpretation. At the same time, for professional healthcare needs including consultations for complex conditions, long-term chronic disease management and online prescription services, physicians are deeply involved in diagnosis and treatment decisions. To date, Ping An’s AI Doctor supports accurate diagnosis across more than 11,300 diseases and serves nearly 12 million users annually.